Differences in acute stroke management and outcomes in men versus women

Takeaway

  • Women were significantly less likely to receive endovascular therapy (EVT) or recombinant tissue-type plasminogen activator (r-tPA) and more likely to have poor outcome in a large registry study.

Why this matters

  • Sex differences in the management and outcome of cerebrovascular disease (CBVD) have been reported, but the findings are not conclusive.

  • Analysis of data from a large, prospective registry may improve understanding regarding sex-related discrepancies in management and outcomes of CBVD.